FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3326211000001106: Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26107101000001112 Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
89273501000001118 Clarityn Allergy 10mg tablets (Bayer Plc) 7 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Is a Loratadine 10mg tablets 7 tablet true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Is pack of Clarityn Allergy 10mg tablets (Schering-Plough Ltd) false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has active ingredient Piperidine derivative false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has active ingredient Loratadine false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Legal category General sales list true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has AMP Clarityn Allergy 10mg tablets (Schering-Plough Ltd) true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has specific active ingredient Loratadine true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Clarityn Allergy 10mg tablets (Schering-Plough Ltd) 7 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start